AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.
about
Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signalingAldo-keto reductase family 1 member B8 is secreted via non-classical pathway.Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.Proteomic analysis on N, N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells.A gene signature to determine metastatic behavior in thymomas.Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice.Genetic variants in AKR1B10 associate with human eating behavior.Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase.Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.Low expression of Aldo-keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma.Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival.Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes.AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway.Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesotheliomaHigh expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.Combined Transcriptomic Analysis Revealed AKR1B10 Played an Important Role in Psoriasis through the Dysregulated Lipid Pathway and Overproliferation of Keratinocyte.Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry.Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
P2860
Q27702584-8FF980EE-935A-46AE-8CA2-B754C850D701Q33600379-D2DFAF0C-B62E-46BF-92A1-F41C834502DFQ33779639-6900F07A-FF66-4B84-8891-DB6648FC379CQ34028973-8DB8F1C7-AB7C-4985-9BA0-B193546CC4EFQ34079748-559371DA-548D-4BD2-B910-040BFAAFC855Q34479612-F0A60D33-282F-4857-B95C-50A3717AE602Q34872271-6B3723FF-E9D4-41D6-BE3B-915D9D1630DEQ35178414-21C7DBE0-0380-4F86-8FF2-CAD0646885DEQ35232887-477B3B66-5E41-44A7-856C-B9EFE4E61923Q35723290-112A49DB-2616-46CB-A43D-B884E21D3EC3Q36629475-7B5097E4-797A-4A4D-BC59-562992CE0AEBQ36654211-20056BA8-9935-4BBB-8B20-74702D743381Q36656870-A68D4312-78A5-4588-8157-B043A295ECAFQ37034875-2F2A6B74-E526-4E43-AEFB-639C09B1239AQ37405077-79668DC6-2F47-4064-B9B0-790929B4A3CFQ37536701-2C84B056-2BE3-46D7-8FC1-CC31F8F1E3C9Q37623620-D4D6A8D8-E3D0-43FB-B5F0-CA203B6D1375Q37633872-91035D52-5BCF-41D2-9B17-BAF112EF2CDDQ38834978-B9D69558-77EB-46F1-AE9E-CAB2AB5747C9Q39926530-3A0F93E3-1432-4A09-B0F8-6BA83B342FAFQ47106774-6F71EF10-A69A-4541-A19C-F5F08D66983AQ47202394-834D291E-8FEE-49D8-93FE-9D56A8969A1AQ48116483-A88727C8-DBCA-4356-A42B-AE18D61CE92AQ51069851-5CA88BEE-FED3-4879-B001-4B9CDC7E18C1Q52755069-BE6504F8-2631-4AA5-BBB3-4ADEE9382600Q57492406-5F7E173B-EDD0-4BCB-BA34-D81FA410E307
P2860
AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
AKR1B10 overexpression in brea ...... ntial as a novel serum marker.
@en
AKR1B10 overexpression in brea ...... ntial as a novel serum marker.
@nl
type
label
AKR1B10 overexpression in brea ...... ntial as a novel serum marker.
@en
AKR1B10 overexpression in brea ...... ntial as a novel serum marker.
@nl
prefLabel
AKR1B10 overexpression in brea ...... ntial as a novel serum marker.
@en
AKR1B10 overexpression in brea ...... ntial as a novel serum marker.
@nl
P2093
P2860
P921
P356
P1476
AKR1B10 overexpression in brea ...... ntial as a novel serum marker.
@en
P2093
Chenfei Huang
Deliang Cao
Di-Xian Luo
Duan-Fang Liao
Fengmin Lu
Jianghua Liu
Stephen Markwell
P2860
P304
P356
10.1002/IJC.27618
P577
2012-05-21T00:00:00Z